Skip to main content


Log in

Omission of bone scanning according to staging guidelines leads to futile therapy in non-small cell lung cancer

  • Original Article
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript


The leading European and American professional societies recommend that bone scans (BS) should be performed in the staging of lung cancer only in those patients with bone pain. This prospective study investigated the sensitivity of conventional skeletal scintigraphy in detecting osseous metastases in patients with lung cancer and addressed the potential consequences of failure to use this method in the work-up of asymptomatic patients. Subsequent to initial diagnosis of non-small cell lung cancer, 100 patients were examined and questioned regarding skeletal complaints. Two specialists in internal medicine decided whether they would recommend a bone scan on the basis of the clinical evaluation. Skeletal scintigraphy was then performed blinded to the findings of history and physical examination. The combined results of magnetic resonance imaging (MRI) of the vertebral column, positron emission tomography (PET) of skeletal bone and the subsequent clinical course served as the gold standard for the identification of osseous metastases. Bone scintigraphy showed an 87% sensitivity in the detection of bone metastases. Failure to perform skeletal scintigraphy in asymptomatic patients reduced the sensitivity of the method, depending on the interpretation of the symptoms, to 19–39%. Without the findings of skeletal scintigraphy and the gold standard methods, 14–22% of patients would have undergone unnecessary surgery or neoadjuvant therapy. On this basis it is concluded that bone scans should not be omitted in asymptomatic patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others


  1. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111:1710–1717.

    PubMed  Google Scholar 

  2. Spiro SG, Porter JC. Lung cancer—where are we today? Current advances in staging and nonsurgical treatment. Am J Respir Crit Care Med 2002; 166:1166–1196.

    Article  PubMed  Google Scholar 

  3. Michel F, Soler M, Imhof E, Perruchoud AP. Initial staging of non-small cell lung cancer: value of routine radioisotope bone scanning. Thorax 1991; 46:469–473.

    CAS  PubMed  Google Scholar 

  4. Yano T, Yokoyama H, Inoue T, et al. The first site of recurrence after complete resection in non-small-cell carcinoma of the lung. Comparison between pN0 disease and pN2 disease. J Thorac Cardiovasc Surg 1994; 108:680–683.

    CAS  PubMed  Google Scholar 

  5. Osada H, Nakajima Y, Taira Y, Yokote K, Noguchi T. The role of mediastinal and multi-organ CT scans in staging presumable surgical candidates with non-small-cell lung cancer. Jpn J Surg 1987; 17:362–368.

    CAS  PubMed  Google Scholar 

  6. Salvatierra A, Baamonde C, Llamas JM, Cruz F, Lopez-Pujol J. Extrathoracic staging of bronchogenic carcinoma. Chest 1990; 97:1052–1058.

    CAS  PubMed  Google Scholar 

  7. Hooper RG, Beechler CR, Johnson MC. Radioisotope scanning in the initial staging of bronchogenic carcinoma. Am Rev Respir Dis 1978; 118:279–286.

    CAS  PubMed  Google Scholar 

  8. Ramsdell JW, Peters RM, Taylor AT Jr., Alazraki NP, Tisi GM. Multiorgan scans for staging lung cancer. Correlation with clinical evaluation. J Thorac Cardiovasc Surg 1977; 73:53–59.

    Google Scholar 

  9. Turner P, Haggith JW. Preoperative radionuclide scanning in bronchogenic carcinoma. Br J Dis Chest 1981; 75:291–294.

    CAS  PubMed  Google Scholar 

  10. Tornyos K, Garcia O, Karr B, LeBeaud R. A correlation study of bone scanning with clinical and laboratory findings in the staging of nonsmall-cell lung cancer. Clin Nucl Med 1991; 16:107–109.

    CAS  PubMed  Google Scholar 

  11. Toloza EM, Harpole L, McCrory DC. Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest 2003; 123:137S–146S.

    Article  PubMed  Google Scholar 

  12. Haubold-Reuter BG, Duewell S, Schilcher BR, Marincek B, von Schulthess GK. The value of bone scintigraphy, bone marrow scintigraphy and fast spin-echo magnetic resonance imaging in staging of patients with malignant solid tumors: a prospective study. Eur J Nucl Med 1993; 20:1063–1069.

    PubMed  Google Scholar 

  13. Hochstenbag MM, Snoep G, Cobben NA, et al. Detection of bone marrow metastases in small cell lung cancer. Comparison of magnetic resonance imaging with standard methods. Eur J Cancer 1996; 32A:779–782.

    Article  CAS  PubMed  Google Scholar 

  14. Schirrmeister H, Guhlmann A, Elsner K, et al. Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus18F PET. J Nucl Med 1999; 40:1623–1629.

    CAS  PubMed  Google Scholar 

  15. Schirrmeister H, Guhlmann A, Kotzerke J, et al. Early detection and accurate description of extent of metastatic bone disease in breast cancer with18F-fluoride ion and positron emission tomography. J Clin Oncol 1999; 17:2381–2389.

    CAS  PubMed  Google Scholar 

  16. Krasnow AZ, Hellman RS, Timins ME, Collier BD, Anderson T, Isitman AT. Diagnostic bone scanning in oncology. Semin Nucl Med 1997; 27:107–141.

    CAS  PubMed  Google Scholar 

  17. Robertson JT. The rape of the spine. Surg Neurol 1993; 39:5–12.

    CAS  PubMed  Google Scholar 

  18. Deyo RA, Tsui-Wu Y-J. Descriptive epidemiology of low-back pain and its related medical care in the United States. Spine 1987; 12:264–268.

    CAS  PubMed  Google Scholar 

  19. Pretreatment evaluation of non-small-cell lung cancer. The American Thoracic Society and The European Respiratory Society. Am J Respir Crit Care Med 1997; 156:320–332.

    PubMed  Google Scholar 

  20. Silvestri GA, Tanoue LT, Margolis ML, Barker J, Detterbeck F. The noninvasive staging of non-small cell lung cancer: the guidelines. Chest 2003; 123:147S–156S.

    Article  PubMed  Google Scholar 

  21. Citrin DL, Bessent RG, Greig WR. A comparison of the sensitivity and accuracy of the99mTc-phosphate bone scan and skeletal radiograph in the diagnosis of bone metastases. Clin Radiol 1977; 28:107–117.

    CAS  PubMed  Google Scholar 

  22. Frank JA, Ling A, Patronas NJ, et al. Detection of malignant bone tumors: MR imaging vs scintigraphy. Am J Roentgenol 1990; 155:1043–1048.

    CAS  Google Scholar 

  23. Even-Sapir E, Martin RH, Barnes DC, Pringle CR, Iles SE, Mitchell MJ. Role of SPECT in differentiating malignant from benign lesions in the lower thoracic and lumbar vertebrae. Radiology 1993; 187:193–198.

    CAS  PubMed  Google Scholar 

  24. Schiller JH, Harrington D, Belani CP, et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 2002; 346:92–98.

    Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Martin Hetzel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schirrmeister, H., Arslandemir, C., Glatting, G. et al. Omission of bone scanning according to staging guidelines leads to futile therapy in non-small cell lung cancer. Eur J Nucl Med Mol Imaging 31, 964–968 (2004).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: